Health1 min read

STAT+: NIAID acting head John Powers III appointed as the permanent director

By · Via STAT Health · Published by Everything Blog

In short

John Powers III brings decades of experience to the role, having contributed to the agency in clinical research positions since 1999 before stepping in as acting head in June. His confirmation stabilizes a post that remained vacant after Jeanne Marrazzo was removed by the Trump administration in March 2025. Following Marrazzo's exit, interim leader Jeffery Taubenberger abruptly resigned while multiple other top officials faced reassignments or resignation requests. The leadership shift unfolds as the agency continues confronting political pressure tied to former director Anthony Fauci.

Key points

  • The agency has officially solidified its top leadership following months of unexpected ad…: The agency has officially solidified its top leadership following months of unexpected administrative turnover.
  • Institutional stability returns as the organization navigates sustained political scrutin…: Institutional stability returns as the organization navigates sustained political scrutiny from the second Trump administration.
  • The new permanent director assumes control amid ongoing controversies surrounding past le…: The new permanent director assumes control amid ongoing controversies surrounding past leadership and funded research in China.

Sources checked by our analysis pipeline: 1

The acting director of the National Institutes of Allergy and Infectious Diseases, John Powers III, will become the permanent director, the agency announced Monday.

NIAID has been without a permanent director since March 2025, when the Trump administration ousted Jeanne Marrazzo. Powers has been serving in an acting capacity since June. A physician-scientist, Powers has worked with NIAID since 1999 in several roles focused on clinical research.

The second Trump administration has brought a renewed spotlight to the infectious disease institute, in large part because of the president’s ire for former director Anthony Fauci, and because of unsubstantiated accusations that research funded by the institute in China played a role in creating the SARS-CoV-2 virus. It has also seen tumult in its leadership. After Marrazzo was ousted, Jeffery Taubenberger was appointed acting director. He unexpectedly stepped down, and several other leaders at NIAID were reassigned to other institutes or asked to resign.

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already…

Health